Tennessee Senate Bill SB0260

Tennessee 2025-2026 Regular Session

• Introduced: 1/23/25

Caption

AN ACT to amend Tennessee Code Annotated, Title 44; Title 47, Chapter 18 and Title 53, relative to meat.

Summary

Senate Bill 260 would amend Tennessee law to define “mRNA vaccine or vaccine material” in the animal health/meat labeling statutes and to expressly allow meat or meat products to be labeled “mRNA free” or with a similar designation, so long as the animals used to produce the meat were not administered an mRNA vaccine or vaccine material. The bill is narrowly focused on labeling and does not create a general prohibition on the use of mRNA vaccines in animals. The measure appears intended to address consumer labeling concerns in the meat market by giving producers a clear legal basis to market products based on whether livestock received mRNA-related veterinary treatments. It would add a new definition to Tennessee Code Annotated and create an explicit safe harbor for “mRNA free” claims, potentially affecting meat producers, processors, retailers, and regulators overseeing labeling practices.

Impact

SB0260 would amend Tennessee Code Annotated Title 53, which governs animal health and related matters, by adding a statutory definition of “mRNA vaccine or vaccine material” and clarifying that meat labeling laws do not bar “mRNA free” claims when the underlying animals were not given such vaccines or materials. The practical effect is to authorize a specific marketing claim and reduce uncertainty about whether such labeling could be challenged under state law. It may also influence enforcement and consumer-protection review of meat labels under related provisions in Titles 44, 47, and 53.

Sentiment

No committee transcripts or recorded votes were provided, so there is no direct evidence of legislative debate or formal support/opposition in the available record. Based on the bill text alone, the proposal appears to be framed as a consumer-information and labeling measure rather than a broad regulatory change. The absence of recorded discussion makes the overall sentiment difficult to gauge beyond the bill’s apparent intent to provide clarity for producers who wish to make “mRNA free” claims.

Contention

The likely point of contention is whether “mRNA free” labeling is meaningful, scientifically accurate, or potentially misleading to consumers, especially if the term could imply a broader safety or quality claim beyond the specific absence of mRNA vaccines in the animals. Another possible issue is whether the bill could encourage market confusion or conflict with existing labeling standards and federal oversight of meat products. Supporters would likely emphasize labeling transparency and producer certainty, while critics may question the necessity of singling out mRNA vaccines in meat marketing.